RecruitingNot ApplicableNCT07160036

Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Therapy

Exploring the Repeatability of Adaptive Optics Scanning Laser Ophthalmoscope Technology (AO-SLO Mona IIa) and the Differences in Cone Cell Density Between Individuals Who Undergone and Not Undergone Repeated Low-level Red-light

Sponsor

Ruihua Wei

Enrollment

180 participants

Start Date

Sep 20, 2025

Study Type

INTERVENTIONAL

Conditions

Myopia

Summary

To explore the repeatability of AO-SLO (Mona IIa) technology and the difference of cone cell density between individuals who used or not used repeated low-intensity red light treatment

Eligibility

Min Age: 6 YearsMax Age: 55 Years

Inclusion Criteria1

- 55 years old, gender not limited; Obtained informed consent.

Exclusion Criteria11

Children with obvious strabismus and amblyopia
With congenital eye disease, such as congenital cataract, congenital retinal disease
Secondary myopia (such as premature retinopathy or other eye diseases in infants and children caused secondary myopia), or myopia combined with systemic syndrome (such as Marfan syndrome)
Had internal eye surgery (such as cataract extraction, intraocular lens implantation, anti-glaucoma surgery, etc.)
Refractive medium opacity (such as corneal disease, crystal opacity, etc.)
Bnormal intraocular pressure and clinical significance (IOP <10 mmHg or IOP>21mmHg or binocular IOP difference ≥5mmHg)
Fundus chorioretinopathy (except for high myopia fundus degenerative changes) or other intraocular diseases
Optic nerve damage or congenital optic nerve dysfunction
Can not be regularly checked
The adjustment range is less than 8D or obvious near difficulties
Other reasons researchers think it is not suitable for inclusion in researchers